These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20828977)

  • 1. FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrences.
    de Jong JS; van Ginkel RJ; Slart RH; Lemstra CL; Paans AM; Mulder NH; Hoekstra HJ
    Eur J Surg Oncol; 2010 Nov; 36(11):1092-5. PubMed ID: 20828977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.
    Oechsle K; Hartmann M; Brenner W; Venz S; Weissbach L; Franzius C; Kliesch S; Mueller S; Krege S; Heicappell R; Bares R; Bokemeyer C; de Wit M;
    J Clin Oncol; 2008 Dec; 26(36):5930-5. PubMed ID: 19018083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
    Cohn DE; Hall NC; Povoski SP; Seamon LG; Farrar WB; Martin EW
    Gynecol Oncol; 2008 Aug; 110(2):152-7. PubMed ID: 18539314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma.
    Decoene J; Winter C; Albers P
    Urol Oncol; 2015 Jan; 33(1):23.e15-23.e21. PubMed ID: 25454484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET-Probe: Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery.
    Gulec SA; Daghighian F; Essner R
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):9020-9027. PubMed ID: 16865592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we rely on PET in the follow-up of advanced seminoma patients?
    Siekiera J; Małkowski B; Jóźwicki W; Jasiński M; Wronczewski A; Pietrzak T; Chmielowska E; Petrus A; Kamecki K; Mikołajczak W; Kraśnicki K; Chłosta P; Drewa T
    Urol Int; 2012; 88(4):405-9. PubMed ID: 22507953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET probe-guided surgery: applications and clinical protocol.
    Gulec SA; Hoenie E; Hostetter R; Schwartzentruber D
    World J Surg Oncol; 2007 Jun; 5():65. PubMed ID: 17555587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of
    Hung TJ; McLean L; Mitchell C; Pascoe C; Lawrentschuk N; Murphy DG; Iravani A; Singh D; Hofman MS; Zidan L; Akhurst T; Lewin J; Hicks RJ
    Cancer Imaging; 2019 May; 19(1):28. PubMed ID: 31142361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluorodeoxyglucose F18(FDG)-probe guided biopsy].
    Hartemink KJ; Muller S; Smulders YM; Petrousjka van den Tol M; Comans EF
    Ned Tijdschr Geneeskd; 2010; 154():A1884. PubMed ID: 20858312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.
    Becherer A; De Santis M; Karanikas G; Szabó M; Bokemeyer C; Dohmen BM; Pont J; Dudczak R; Dittrich C; Kletter K
    Eur J Radiol; 2005 May; 54(2):284-8. PubMed ID: 15837411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG PET/CT imaging in a case of primary choriocarcinoma in the retroperitoneum.
    Cimarelli S; Deshayes E; Mognetti T; Biron P; Desuzinges C; Rivoire M; Giammarile F
    Clin Nucl Med; 2009 Jul; 34(7):449-51. PubMed ID: 19542954
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioguided surgery using an intraoperative PET probe for tumor localization and verification of complete resection in differentiated thyroid cancer: a pilot study.
    Kim WW; Kim JS; Hur SM; Kim SH; Lee SK; Choi JH; Kim S; Choi JY; Lee JE; Kim JH; Nam SJ; Yang JH; Choe JH
    Surgery; 2011 Mar; 149(3):416-24. PubMed ID: 20965536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
    Thrall MM; DeLoia JA; Gallion H; Avril N
    Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET in testicular cancer.
    Becherer A
    Methods Mol Biol; 2011; 727():225-41. PubMed ID: 21331937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
    Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
    Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.
    Cremerius U; Wildberger JE; Borchers H; Zimny M; Jakse G; Günther RW; Buell U
    Urology; 1999 Nov; 54(5):900-4. PubMed ID: 10565755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.